ELIZABETH VIDAL: Open Payments
NPI 1205330198 · WINTER GARDEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$761 in 31 payments from 14 companies in 2025. Trend: 2023 $1,456 · 2024 $2,059 · 2025 $761
Food & beverage: $761
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 8 | $192 |
| Janssen Biotech, Inc. | 3 | $156 |
| GENZYME CORPORATION | 3 | $67 |
| Novartis Pharmaceuticals Corporation | 2 | $63 |
| ABBVIE INC. | 3 | $59 |
| Botanix SB Inc | 2 | $32 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| Almirall LLC | 1 | $27 |
| Lilly USA, LLC | 1 | $26 |
Products named: DUPIXENT, TREMFYA, COSENTYX, SKYRIZI, SOFDRA, SPEVIGO, Seysara, TALTZ.
Industry payments across FL — which companies pay providers there.
